Legislation to increase access to breast and cervical cancer screening introduced in the Senate

NCI Cancer Information Highlights bulletin cut due to RIFs

NCI’s Cancer Information Highlights bulletin, a section of NCI’s Weekly Digest Bulletin that informs readers of research updates related to cancer causes, prevention, screening, treatment, and coping, will no longer be published due to restructuring and reductions in force at HHS.

May 23, 2025

Vol.51 No.20

Cancer Policy

House passes Trump’s spending bill, which now moves to the Senate

The U.S. House of Representatives voted on the so-called “One Big, Beautiful Bill Act,” this week which included drastic, $715 billion cuts to Medicaid that will result in at least 8.6 million people losing health insurance coverage, including cancer patients and survivors.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

In Brief

NRG Oncology appoints new leaders to Cancer Prevention and Control Committee

NRG Oncology, an NCI National Clinical Trials Network group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced new chair and vice chair appointments to the NRG NCI Community Oncology Research Program Cancer Prevention & Control Committee.

May 23, 2025

Vol.51 No.20

In Brief

CPRIT awards more than $93M for cancer research and prevention

On May 21, the governing body of the Cancer Prevention and Research Institute of Texas approved 61 grants totaling more than $93 million. The grants support cancer research and prevention projects across the entire spectrum of CPRIT’s mission, including CPRIT Scholar recruitment grants, a wide array of evidence-based prevention programs, and funding for early-stage companies developing promising new treatments for cancer.

May 23, 2025

Vol.51 No.20

Clinical Roundup

“Fast-fail” AI blood test could steer patients with pancreatic cancer away from ineffective therapies

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient’s blood, developed by Johns Hopkins Kimmel Cancer Center investigators, could help clinicians more quickly identify and determine if pancreatic cancer therapies are working.

May 23, 2025

Vol.51 No.20